DK1389137T3 - Sammensætninger til lungelægemiddellevering af protein - Google Patents

Sammensætninger til lungelægemiddellevering af protein

Info

Publication number
DK1389137T3
DK1389137T3 DK02737094T DK02737094T DK1389137T3 DK 1389137 T3 DK1389137 T3 DK 1389137T3 DK 02737094 T DK02737094 T DK 02737094T DK 02737094 T DK02737094 T DK 02737094T DK 1389137 T3 DK1389137 T3 DK 1389137T3
Authority
DK
Denmark
Prior art keywords
protein
compositions
drug delivery
lung drug
formulations
Prior art date
Application number
DK02737094T
Other languages
Danish (da)
English (en)
Inventor
Stephen Francis Goodall
Michael John Waters
Stephen Michael Mahler
Hak-Kim Chan
Nora Y K Chew
Original Assignee
Injet Digital Aerosols Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23126170&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1389137(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Injet Digital Aerosols Ltd filed Critical Injet Digital Aerosols Ltd
Application granted granted Critical
Publication of DK1389137T3 publication Critical patent/DK1389137T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
    • A61M11/001—Particle size control
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
    • A61M11/04—Sprayers or atomisers specially adapted for therapeutic purposes operated by the vapour pressure of the liquid to be sprayed or atomised
    • A61M11/041—Sprayers or atomisers specially adapted for therapeutic purposes operated by the vapour pressure of the liquid to be sprayed or atomised using heaters
    • A61M11/042—Sprayers or atomisers specially adapted for therapeutic purposes operated by the vapour pressure of the liquid to be sprayed or atomised using heaters electrical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0065—Inhalators with dosage or measuring devices
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/02—Inhalators with activated or ionised fluids, e.g. electrohydrodynamic [EHD] or electrostatic devices; Ozone-inhalators with radioactive tagged particles
    • A61M15/025—Bubble jet droplet ejection devices
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
DK02737094T 2001-05-21 2002-05-21 Sammensætninger til lungelægemiddellevering af protein DK1389137T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US29278301P 2001-05-21 2001-05-21

Publications (1)

Publication Number Publication Date
DK1389137T3 true DK1389137T3 (da) 2006-10-30

Family

ID=23126170

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02737094T DK1389137T3 (da) 2001-05-21 2002-05-21 Sammensætninger til lungelægemiddellevering af protein

Country Status (12)

Country Link
US (2) US20030064052A1 (es)
EP (1) EP1389137B1 (es)
JP (2) JP5342730B2 (es)
CN (1) CN1236831C (es)
AT (1) ATE333290T1 (es)
AU (1) AU2002310054B2 (es)
CA (1) CA2448022C (es)
DE (1) DE60213228T2 (es)
DK (1) DK1389137T3 (es)
ES (1) ES2268044T3 (es)
HK (1) HK1058902A1 (es)
WO (1) WO2002094342A2 (es)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4147234B2 (ja) 2004-09-27 2008-09-10 キヤノン株式会社 吐出用液体、吐出方法、カートリッジ及び吐出装置
US20030072717A1 (en) * 2001-02-23 2003-04-17 Vapotronics, Inc. Inhalation device having an optimized air flow path
AU2002310054B2 (en) * 2001-05-21 2007-02-01 Injet Digital Aerosols Limited Compositions for protein delivery via the pulmonary route
BR0306811A (pt) 2002-01-11 2004-10-26 Sankyo Co Composto, éster farmacologicamente aceitável do mesmo, composição farmacêutica e métodos para prevenção ou tratamento de doenças autoimunes, da artrite reumatóide e da rejeição causada pelo transplante de vários órgãos em um mamìfero
US7683029B2 (en) * 2003-05-07 2010-03-23 Philip Morris Usa Inc. Liquid aerosol formulations containing insulin and aerosol generating devices and methods for generating aerosolized insulin
KR20110136901A (ko) 2004-02-24 2011-12-21 상꾜 가부시키가이샤 아미노 알코올 화합물
JP4564936B2 (ja) * 2006-03-27 2010-10-20 キヤノン株式会社 吐出用液体、吐出方法、液滴化方法、液体吐出カートリッジ及び吐出装置
JP4147235B2 (ja) * 2004-09-27 2008-09-10 キヤノン株式会社 吐出用液体、吐出方法、液滴化方法、液体吐出カートリッジ及び吐出装置
JP4646669B2 (ja) 2005-03-30 2011-03-09 キヤノン株式会社 吐出用液体、吐出方法、液滴化方法、カートリッジ及び吐出装置
JP4689340B2 (ja) * 2005-05-02 2011-05-25 キヤノン株式会社 吐出用液体医薬組成物
CN100394981C (zh) * 2005-09-16 2008-06-18 深圳市孚沃德生物技术有限公司 一种人粒细胞巨噬细胞集落刺激因子喷雾剂及其制备方法
TWI299993B (en) * 2005-12-15 2008-08-21 Dev Center Biotechnology Aqueous inhalation pharmaceutical composition
JP2007254421A (ja) * 2006-03-24 2007-10-04 Canon Inc 吐出用液体、吐出方法、吐出用カートリッジ、吐出装置及び吐出用液体の液滴化方法
JP4777225B2 (ja) 2006-12-04 2011-09-21 キヤノン株式会社 吐出用液体及び吐出方法
US20120214964A1 (en) * 2011-02-23 2012-08-23 Elona Biotechnologies Liquid insulin compositions and methods of making the same
US10100098B2 (en) 2006-12-13 2018-10-16 Stelis Biopharma Private Limited Insulin production methods and proinsulin constructs
JP5110898B2 (ja) * 2007-02-16 2012-12-26 キヤノン株式会社 吐出用液体及び吐出方法
EA201000785A1 (ru) * 2007-12-13 2011-02-28 Глаксо Груп Лимитед Композиции для доставки в легкие
CA2742710A1 (en) 2008-11-04 2010-05-14 Janssen Pharmaceutica Nv Crhr2 peptide agonists and uses thereof
JP5597844B2 (ja) * 2009-04-29 2014-10-01 テレコム・イタリア・エッセ・ピー・アー 基板上へ生物流体を付着させるための方法及び装置
EP2496248A2 (en) 2009-11-04 2012-09-12 Janssen Pharmaceutica, N.V. Method for treating heart failure with stresscopin-like peptides
US10034988B2 (en) 2012-11-28 2018-07-31 Fontem Holdings I B.V. Methods and devices for compound delivery
US10194693B2 (en) 2013-09-20 2019-02-05 Fontem Holdings 1 B.V. Aerosol generating device
JP7480338B2 (ja) 2019-12-15 2024-05-09 シャヒーン イノベーションズ ホールディング リミテッド 超音波ミスト吸入器
US11730191B2 (en) 2019-12-15 2023-08-22 Shaheen Innovations Holding Limited Hookah device
EP3860696B1 (en) 2019-12-15 2024-04-10 Shaheen Innovations Holding Limited Ultrasonic mist inhaler
SI3837999T1 (sl) 2019-12-15 2022-10-28 Shaheen Innovations Holding Limited Naprave za inhaliranje meglic
US11589610B2 (en) 2019-12-15 2023-02-28 Shaheen Innovations Holding Limited Nicotine delivery device having a mist generator device and a driver device
US11730193B2 (en) 2019-12-15 2023-08-22 Shaheen Innovations Holding Limited Hookah device
US11666713B2 (en) 2019-12-15 2023-06-06 Shaheen Innovations Holding Limited Mist inhaler devices
KR20220141281A (ko) 2019-12-15 2022-10-19 샤힌 이노베이션즈 홀딩 리미티드 초음파 미스트 흡입장치
US20230188901A1 (en) 2021-12-15 2023-06-15 Shaheen Innovations Holding Limited Apparatus for transmitting ultrasonic waves

Family Cites Families (72)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US455614A (en) * 1891-07-07 Sivioking device
US37053A (en) * 1862-12-02 Improved me at-cutter
US1105934A (en) * 1913-07-12 1914-08-04 Ernest J Stevens Inhaler.
US1272579A (en) * 1918-01-26 1918-07-16 George W Todd Dispensing-receptacle for liquid anesthetics.
US2084299A (en) * 1934-12-15 1937-06-15 Arthur G Borden Medicament holder for nasal inhalers
US2086588A (en) * 1935-11-18 1937-07-13 Joseph J Tobin Vaporizing applicator
US2449853A (en) * 1947-08-05 1948-09-21 Karp George Inhaler
DE2160561C3 (de) * 1971-12-07 1985-05-15 Hanns-Joachim Dr. 5000 Köln Hirtz Vorrichtung zum Behandeln der Atmungswege mit Warmluft
US3812854A (en) * 1972-10-20 1974-05-28 A Michaels Ultrasonic nebulizer
DE2445791C2 (de) * 1974-09-25 1984-04-19 Siemens AG, 1000 Berlin und 8000 München Ultraschall-Flüssigkeitszerstäuber
JPS5953565A (ja) * 1982-09-20 1984-03-28 Dainippon Toryo Co Ltd ジエツトインク組成物
US4685968A (en) * 1985-12-05 1987-08-11 Hewlett-Packard Company Process for preparing ink compositions for ink-jets printers
US4653494A (en) * 1985-12-20 1987-03-31 Ruderian Max J Nasal inhalation system
US4694302A (en) * 1986-06-06 1987-09-15 Hewlett-Packard Company Reactive ink-jet printing
US4735217A (en) * 1986-08-21 1988-04-05 The Procter & Gamble Company Dosing device to provide vaporized medicament to the lungs as a fine aerosol
US5047064A (en) * 1987-06-03 1991-09-10 Sandoz Ltd. Method and composition for the alkali treatment of cellulosic substrates
US4922901A (en) * 1988-09-08 1990-05-08 R. J. Reynolds Tobacco Company Drug delivery articles utilizing electrical energy
JP2931846B2 (ja) * 1988-11-07 1999-08-09 松下電器産業株式会社 パネルスイッチおよびその製造法
US5225183A (en) * 1988-12-06 1993-07-06 Riker Laboratories, Inc. Medicinal aerosol formulations
US5062892A (en) * 1989-10-27 1991-11-05 Hewlett-Packard Company Ink additives for improved ink-jet performance
US5060671A (en) * 1989-12-01 1991-10-29 Philip Morris Incorporated Flavor generating article
US5144962A (en) * 1989-12-01 1992-09-08 Philip Morris Incorporated Flavor-delivery article
US5152456A (en) * 1989-12-12 1992-10-06 Bespak, Plc Dispensing apparatus having a perforate outlet member and a vibrating device
US5047084A (en) * 1990-01-23 1991-09-10 Hewlett-Packard Company Microemulsion ink jet ink composition
DE59007645D1 (de) * 1990-06-21 1994-12-08 Edith Dr Huland Verwendung zytokinhaltiger Aerosole und zytokinhaltige Aerosole selbst.
DE4026072A1 (de) * 1990-08-17 1992-02-20 Sanol Arznei Schwarz Gmbh Nitroglycerinhaltiger, hydrophiler, waessriger pumpspray
GB9027363D0 (en) * 1990-12-18 1991-02-06 Gillette Co Shampoo compositions
JP3532204B2 (ja) * 1991-03-05 2004-05-31 アラダイム コーポレーション 流量計の圧力センサのドリフトオフセットを補正する方法および装置
US5404871A (en) * 1991-03-05 1995-04-11 Aradigm Delivery of aerosol medications for inspiration
US5450336A (en) * 1991-03-05 1995-09-12 Aradigm Corporation Method for correcting the drift offset of a transducer
US5505214A (en) * 1991-03-11 1996-04-09 Philip Morris Incorporated Electrical smoking article and method for making same
US5120528A (en) * 1991-06-12 1992-06-09 Block Drug Company, Inc. Taste preserving, mild oral hygiene compositions
US5413732A (en) * 1991-08-19 1995-05-09 Abaxis, Inc. Reagent compositions for analytical testing
US5170782A (en) * 1991-09-12 1992-12-15 Devilbiss Health Care, Inc. Medicament nebulizer with improved aerosol chamber
DE4134665A1 (de) * 1991-10-19 1993-04-22 Solvay Deutschland Medizinisches inhalationssystem
GB2291605B (en) * 1991-11-12 1996-05-01 Medix Ltd A nebuliser and nebuliser control system
US5206219A (en) * 1991-11-25 1993-04-27 Applied Analytical Industries, Inc. Oral compositions of proteinaceous medicaments
US5639441A (en) * 1992-03-06 1997-06-17 Board Of Regents Of University Of Colorado Methods for fine particle formation
FR2690634B1 (fr) * 1992-04-29 1994-10-14 Chronotec Dispositif de micro-pulvérisation générée par ondes ultra-sonores.
JP3178945B2 (ja) * 1992-08-25 2001-06-25 日本碍子株式会社 インクジェットプリントヘッド
GB9225098D0 (en) * 1992-12-01 1993-01-20 Coffee Ronald A Charged droplet spray mixer
DE4300880C2 (de) * 1993-01-15 1996-03-21 Draegerwerk Ag Ultraschallvernebler mit Dosiereinheit
US5724957A (en) * 1993-01-29 1998-03-10 Aradigm Corporation Intrapulmonary delivery of narcotics
US5354934A (en) * 1993-02-04 1994-10-11 Amgen Inc. Pulmonary administration of erythropoietin
US5429302A (en) * 1993-05-19 1995-07-04 Fisons Corporation Nebulizing element and device
US5666977A (en) * 1993-06-10 1997-09-16 Philip Morris Incorporated Electrical smoking article using liquid tobacco flavor medium delivery system
WO1995001137A1 (en) * 1993-06-29 1995-01-12 Voges Innovation Pty. Ltd. Dispenser
WO1995003034A1 (en) * 1993-07-19 1995-02-02 Amgen Inc. Stabilization of aerosolized proteins
US5388574A (en) * 1993-07-29 1995-02-14 Ingebrethsen; Bradley J. Aerosol delivery article
US5514670A (en) * 1993-08-13 1996-05-07 Pharmos Corporation Submicron emulsions for delivery of peptides
US6228383B1 (en) * 1994-03-03 2001-05-08 Gs Development Ab Use of fatty acid esters as bioadhesive substances
DK0752855T3 (da) * 1994-03-30 2000-01-03 Gs Dev Ab Anvendelse af fedtsyreestere som bioadhæsive substanser
AU701843B2 (en) * 1995-03-14 1999-02-04 Siemens Aktiengesellschaft Removable precision dosating unit for ultrasonic atomizer device
US5808637A (en) * 1995-05-26 1998-09-15 Hewlett-Packard Company Method and apparatus for ink drop trajectory control
US5715866A (en) * 1995-12-29 1998-02-10 Granger; Melforde A. Portable fluid dispensing apparatus
US6026809A (en) * 1996-01-25 2000-02-22 Microdose Technologies, Inc. Inhalation device
US5694920A (en) * 1996-01-25 1997-12-09 Abrams; Andrew L. Inhalation device
USRE37053E1 (en) * 1996-05-24 2001-02-13 Massachusetts Institute Of Technology Particles incorporating surfactants for pulmonary drug delivery
US5985309A (en) * 1996-05-24 1999-11-16 Massachusetts Institute Of Technology Preparation of particles for inhalation
US5976573A (en) * 1996-07-03 1999-11-02 Rorer Pharmaceutical Products Inc. Aqueous-based pharmaceutical composition
US5934289A (en) * 1996-10-22 1999-08-10 Philip Morris Incorporated Electronic smoking system
ATE298740T1 (de) * 1997-04-04 2005-07-15 Mitsubishi Pharma Corp 2-aminopropan-1,3-diol-verbindungen, ihre medizinische anwendung und zwischenprodukte zu ihrer synthese
AU743399B2 (en) * 1997-06-25 2002-01-24 Teijin Limited Vitamin d3 derivatives and remedies for inflammatory respiratory diseases prepared from the same
US6946117B1 (en) * 1997-09-29 2005-09-20 Nektar Therapeutics Stabilized preparations for use in nebulizers
ATE239447T1 (de) * 1997-09-29 2003-05-15 Inhale Therapeutic Syst In verneblern verwendbare, stabilisierte zubereitungen
AU4894697A (en) * 1997-10-01 1999-04-23 Flemington Pharmaceutical Corporation Buccal, polar and non-polar spray or capsule
US6241969B1 (en) * 1998-06-26 2001-06-05 Elan Corporation Plc Aqueous compositions containing corticosteroids for nasal and pulmonary delivery
US6566345B2 (en) * 2000-04-28 2003-05-20 Fziomed, Inc. Polyacid/polyalkylene oxide foams and gels and methods for their delivery
JP4147234B2 (ja) * 2004-09-27 2008-09-10 キヤノン株式会社 吐出用液体、吐出方法、カートリッジ及び吐出装置
US6767637B2 (en) * 2000-12-13 2004-07-27 Purdue Research Foundation Microencapsulation using ultrasonic atomizers
AU2002310054B2 (en) * 2001-05-21 2007-02-01 Injet Digital Aerosols Limited Compositions for protein delivery via the pulmonary route
JP4933046B2 (ja) * 2002-09-06 2012-05-16 フィリップ モーリス ユーエスエー インコーポレイテッド 液体エアロゾル製剤、エアロゾル発生装置およびエアロゾル発生方法

Also Published As

Publication number Publication date
CA2448022A1 (en) 2002-11-28
WO2002094342A2 (en) 2002-11-28
US20030064052A1 (en) 2003-04-03
AU2002310054B2 (en) 2007-02-01
JP5342730B2 (ja) 2013-11-13
CA2448022C (en) 2013-11-12
CN1236831C (zh) 2006-01-18
ES2268044T3 (es) 2007-03-16
WO2002094342A3 (en) 2003-03-20
DE60213228T2 (de) 2007-06-21
EP1389137A2 (en) 2004-02-18
JP2011042695A (ja) 2011-03-03
US20090022669A1 (en) 2009-01-22
HK1058902A1 (en) 2004-06-11
DE60213228D1 (de) 2006-08-31
EP1389137B1 (en) 2006-07-19
CN1464791A (zh) 2003-12-31
EP1389137A4 (en) 2005-01-05
JP2004532861A (ja) 2004-10-28
ATE333290T1 (de) 2006-08-15

Similar Documents

Publication Publication Date Title
DK1389137T3 (da) Sammensætninger til lungelægemiddellevering af protein
DK1257254T3 (da) Formuleringer indeholdende et anticholinergt lægemiddel til behandling af kronisk obstruktiv lungesygdom
NO20025568L (no) Stabile farmasöytiske lösningsformuleringer til anvendelse for utmålte doseinhalatorer
WO2005115406A3 (en) 8-(2-hydroxyphenoxy)octyldiethanolamine and salts thereof for delivery of active agents
NO20062504L (no) Sammensetninger og doseringsformer for forbedret absorpsjon
BR9917089A (pt) Composições e métodos para distribuição mucosal
ZA200405657B (en) Formulation & dosage form for the controlled delivery of therapeutic agents.
DK1172114T3 (da) Stabile koncentrerede insulinpræparater til pulmonær indgivelse
EE05074B1 (et) Sulfoonamiid- ja sulfamiidasendatud imidasokinoliinid, nende kasutamine raviks ja neid sisaldavad farmatseutilised preparaadid
WO2001062737A3 (en) Amino pyrazole derivatives useful for the treatment of obesity and other disorders
NO20061840L (no) Legemiddelbelegg som tilveiebringer hoy legemiddeltilsetning og fremgangsmater for a tilveiebringe samme
CY1108532T1 (el) Ενωσεις και συνθεσεις για την παροχη δραστικων παραγοντων
PL379867A1 (pl) Układ dostarczania o kontrolowanym uwalnianiu do podawania donosowego
DK1476138T3 (da) Formuleringer med modificeret frigivelse af mindst én form af tramadol
EE05065B1 (et) Karbamiidasendatud imidasokinoliinid, nende kasutamine raviks ja neid sisaldavad farmatseutilised preparaadid
SE0102276D0 (sv) Device and method for the administration of a medicament
WO2002019969A3 (en) (5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents
NO20054440L (no) Flytende formuleringer av tumornekrosefaktorbindende proteiner
DE60216305D1 (de) Zusammensetzungen zur verabreichung von arzneimittelkombinationen
BR0213379A (pt) Formulação resistente a derramamento de mascaramento de gosto
SG149054A1 (en) Multiparticulate formulations for oral delivery
BRPI0406858A (pt) Liberação controlada de agentes altamente solúveis
DK1957037T3 (da) Farmaceutisk præparat til nasal anvendelse af fentanyl
DK1273301T3 (da) Farmaceutiske præparater baseret på aktive bestanddele der kan anvendes til ulovlig administration
SE0103210D0 (sv) New formulations and use thereof